Compounds > bicalutamide

bicalutamide and Angiogenesis, Pathologic

bicalutamide has been researched along with Angiogenesis, Pathologic in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Byrne, NM; McKenna, DJ; McKeown, SR; Ming, L; Nesbitt, H; Worthington, J1
Kaya, C; Ozyurek, M; Turkeri, LN1
Bhat-Nakshatri, P; Cheng, L; DeGrado, T; Gokmen-Polar, Y; Hutchins, GD; Jayaprakasan, V; Kelich, S; Miller, KD; Miller, MA; Nakshatri, H; Shanmugam, R; Sledge, GW; Sweeney, CJ; Yip-Schneider, M; Zheng, QH1
Biagini, G; Lucarini, G; Mazzucchelli, R; Montironi, R; Pugnaloni, A; Santinelli, A1

Other Studies

4 other study(ies) available for bicalutamide and Angiogenesis, Pathologic

ArticleYear
Androgen deprivation in LNCaP prostate tumour xenografts induces vascular changes and hypoxic stress, resulting in promotion of epithelial-to-mesenchymal transition.
    British journal of cancer, 2016, Mar-15, Volume: 114, Issue:6

    Topics: Androgen Antagonists; Anilides; Animals; Cell Growth Processes; Cell Hypoxia; Cell Line, Tumor; Dose-Response Relationship, Drug; Epithelial-Mesenchymal Transition; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, SCID; Neovascularization, Pathologic; Nitriles; Oxygen; Prostatic Neoplasms; Tosyl Compounds; Xenograft Model Antitumor Assays

2016
Comparison of microvessel densities in rat prostate tissues treated with finasteride, bicalutamide and surgical castration: a preliminary study.
    International journal of urology : official journal of the Japanese Urological Association, 2005, Volume: 12, Issue:2

    Topics: Androgen Antagonists; Anilides; Animals; Castration; Dissection; Enzyme Inhibitors; Finasteride; Immunohistochemistry; Male; Neovascularization, Pathologic; Nitriles; Prostate; Rats; Rats, Sprague-Dawley; Tosyl Compounds

2005
Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer model.
    The Prostate, 2006, Oct-01, Volume: 66, Issue:14

    Topics: Androgen Antagonists; Anilides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Bridged-Ring Compounds; Cell Line, Tumor; Docetaxel; Drug Synergism; Endothelium, Vascular; Fibroblast Growth Factor 2; Humans; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mice, Nude; Neovascularization, Pathologic; NF-kappa B; Nitriles; Prostatic Neoplasms; Radionuclide Imaging; Sesquiterpenes; Taxoids; TNF Receptor-Associated Factor 1; TNF Receptor-Associated Factor 2; Tosyl Compounds; Umbilical Veins; Vascular Endothelial Growth Factor A

2006
Vascular endothelial growth factor expression and capillary architecture in high-grade PIN and prostate cancer in untreated and androgen-ablated patients.
    The Prostate, 2000, Sep-15, Volume: 45, Issue:1

    Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Antineoplastic Combined Chemotherapy Protocols; Capillaries; Endothelial Growth Factors; Goserelin; Humans; Immunohistochemistry; Lymphokines; Male; Middle Aged; Neovascularization, Pathologic; Nitriles; Prostatectomy; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Tosyl Compounds; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2000